Effect of γ-linolenic acid or docosahexaenoic acid on tight junction permeability in intestinal monolayer cells and their mechanism by protein kinase C activation and/or eicosanoid formation

Nutrition

Volumn 19, Issue 2, 2003, Pages 150-156

  Usami, Makoto ^a   Komurasaki, Takako ^a   Hanada, Aki ^a   Kinoshita, Kaori ^a   Ohata, Atsushi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

linolenic acid; 2 (12 hydroxydodeca 5,10 diynyl) 3,5,6 trimethyl p benzoquinone; Caco 2 cell; Docosahexaenoic acid; Eicosapentaenoic acid; Indomethacin; Protein kinase C; Tight junction permeability

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; BUTYLCRESOL; DOCEBENONE; DOCOSAHEXAENOIC ACID; FLUORESCEIN; GAMMA LINOLENIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; INDOMETACIN; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; SULFONIC ACID DERIVATIVE;

ARTICLE; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYMATIC DEGRADATION; ENZYME ACTIVATION; ENZYME REGULATION; FILTER; HUMAN; HUMAN CELL; INTESTINE CELL; LIPOGENESIS; NUTRIENT; PRIORITY JOURNAL; TIGHT JUNCTION;

CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CYCLOOXYGENASE INHIBITORS; DOCOSAHEXAENOIC ACIDS; EICOSANOIDS; ELECTRIC IMPEDANCE; FLUORESCEINS; GAMMA-LINOLENIC ACID; HUMANS; INTESTINAL MUCOSA; LIPOXYGENASE INHIBITORS; MODELS, BIOLOGICAL; PROTEIN KINASE C; TIGHT JUNCTIONS;

EID: 0037322853     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(02)00927-9     Document Type: Article

References (25)

1. Alexander J.W. Immunonutrition. The role of ω-3 fatty acids. Nutrition. 14:1998;627.
2. Menconi M.J., Salzman A.L., Unno N., et al. Acidosis induced hyperpermeability in Caco-2BBe cultured intestinal monolayers. Am J Physiol. 272:1994;G633.
3. Jiang W.G., Bryce R.P., Horrobin D.F., Mansel R.E. Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. Biochem Biophys Res Commun. 244:1998;414.
4. Horie T., Nakamura M., Masubuchi Y. Docosahexaenoic acid exhibits a potent protection of small intestine from methotrexate-induced damage in mice. Life Sci. 62:1998;1333.
5. Kajita M., Morishita M., Takayama K., et al. Enhanced enteral bioavailability of vancomycin using water-in-oil-in-water multiple emulsion incorporating highly purified unsaturated fatty acid. J Pharm Sci. 89:2000;1243.
6. Usami M., Muraki K., Iwamoto M., et al. Effect of eicosapentaenoic acid (EPA) on tight junction permeability in intestinal monolayer cells. Clin Nutr. 20:2001;351.
7. Fan Y.Y., Chapkin R.S. Importance of dietary γ-linolenic acid in human health and nutrition. J Nutr. 128:1998;1411.
8. Johnson M.M., Swan D.D., Surette M.E., et al. Dietary supplementation with γ-linolenic acid alters fatty acid content and eicosanoids production in healthy humans. J Nutr. 127:1997;1435.
9. Das U.N., Madhavi N., Kumar G.S., Padma M., Sangeetha P. Can tumor cell drug resistance be reversed by essential fatty acids and their metabolites? Prostaglandins Leukot Essent Fatty Acids. 58:1998;39.
10. Cho Y., Ziboh V.A. A novel 15-hydroxyeicosatrienoic acid-substituted diacylglycerol (15-HETrE-DAG) selectively inhibits epidermal protein kinase C-β Biochim Biophys Acta. 1349:1997;67.
11. Huang Z.H., Hii C.S., Rathjen D.A., et al. n-6 and n-3 polyunsaturated fatty acids stimulate translocation of protein kinase C alpha, -beta I, -beta II and -epsilon and enhance agonist-induced NADPH oxidase in macrophages. Biochem J. 325:(pt 2):1997;553.
12. Calderaro V., Parrillo C., Balestrieri M.L., et al. Docosahexaenoic acid and signaling pathways in rabbit colon. Mol Pharmacol. 45:1994;737.
13. Lindnark T., Kimura Y., Artursson P. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther. 284:1998;362.
14. Stenson W.F., Easom R.A., Riehl T.E., Turk J. Regulation of paracellular permeability in Caco-2 cell monolayers by protein kinase C. Am J Physiol. 265:1993;G955.
15. Turner J.R., Angle J.M., Black E.D., et al. PKC-dependent regulation of transepithelial resistance role of MLC and MLC kinase . Am J Physiol. 277:1999;C554.
16. Darimont C., Gradoux N., Persohn E., Cumin F., De Pover A. Effects of intestinal fatty avid-binding protein overexpression on fatty acid metabolism in Caco-2 cells. J Lipid Res. 41:2000;84.
17. Chen Q.i, Nilsson A. Desaturation and chain elongation of n-3 and n-6 polyunsaturated fatty acids in the human CaCo-2 cell line. Biochim Biophys Acta. 1166:1993;193.
18. Kamitani H., Geller M., Eling T. Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation. J Biol Chem. 273:1998;21569.
19. Cortese J.F., Spannhake E.W., Eisinger W., Potter J.J., Yang V.W. The 5-lipoxygenase pathway in cultured human intestinal epithelial cells. Prostaglandins. 49:1995;155.
20. Reinboth J.J., Clausen M., Reme C.E. Light elicits the release of docosahexaenoic acid from membrane phospholipids in the rat retina in vitro. Exp Eye Res. 63:1996;277.
21. Moody T.W., Leyton J., Martinez A., et al. Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth. Exp Lung Res. 24:1998;617.
22. 1 analogue on the permeability of human small intestine. Jpn J Gastroenterol. 94:1997;475.
23. Sperling R.I., Benincaso A.I., Knoell C.T., et al. Dietary ω-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest. 91:1993;651.
24. Hart C.M., Tolson J.K., Block E.R. Supplementation of fatty acids alter lipid peroxidation and oxidant injury in endothelial cells. Am J Physiol. 260:1991;L481.
25. Cepinskas G., Kvietys P.R., Aw T.Y. ω3-Lipid peroxides injure Cc0-2 cells relationship to the development of reduced glutathione antioxidant systems . Gastroenterology. 107:1994;80.